China NMPA Product Recall - Implantable spinal nerve stimulator

The National Medical Products Administration (NMPA) has publicized a voluntary Class II recall initiated by Medtronic Inc. for its implantable spinal cord stimulators. This recall, reported by Medtronic (Shanghai) Management Co., Ltd. on May 24, 2024, addresses a critical safety concern: the potential for electronic equipment damage to the devices when exposed to cardiac cardioversion procedures. The affected products are identified under National Medical Device Registration No. 20243120025. Medtronic Inc. proactively undertook this recall to mitigate risks to patient safety, acknowledging the potential for device malfunction in specific clinical scenarios. The NMPA's involvement highlights the established regulatory framework governing medical device safety and quality in China, ensuring manufacturers adhere to stringent standards. Further specifics regarding the impacted product models, specifications, and batch numbers are available in the accompanying 'Medical Device Recall Event Report Form.' This action underscores the manufacturer's commitment to product integrity and patient well-being, as well as the NMPA's oversight in safeguarding public health through effective post-market surveillance and recall management.